Return to content in this issue

Mepolizumab as an Effective Alternative to Immunosuppressive and Teratogenic Therapies for the Early Treatment of EGPA: A Case Report

Morejón L¹, Quirce S^1,2, Domínguez-Ortega J^1,2, Romero D^2,3, Noblejas A^2,4, Ríos-Blanco JJ^2,4, De las Vecillas L<sup>1,2

1</sup>Department of Allergy, Hospital Universitario La Paz, Madrid, Spain
²Hospital La Paz Institute for Health Research (IdiPAZ), Madrid, Spain
³Department of Pulmonology, Hospital Universitario La Paz, Madrid, Spain
⁴Department of Internal Medicine, Hospital Universitario La Paz, Madrid, Spain

J Investig Allergol Clin Immunol 2025; Vol. 35(5)
doi: 10.18176/jiaci.1087

• Abstract
• Supplemental Materials

Key words: Eosinophilic granulomatosis with polyangiitis, Eosinophils, Mepolizumab, Corticosteroids, Adrenal insufficiency

	Title	Type	Size
	doi10.18176_jiaci.1087_supplemental-materials-figure.pdf	pdf	96.35 Kb